BC
BSX icon

Bodenholm Capital’s Boston Scientific BSX Stock Holding History

Bodenholm Capital’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-701,100
Closed -$30.1M – 8
2019
Q2 		$30.1M Buy
+701,100
New +$27M 10.64% 5
2018
Q2 		– Sell
-1,207,000
Closed -$33M – 9
2018
Q1 		$33M Buy
+1,207,000
New +$32.8M 20.08% 3

Other funds holding BSX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
BG
Bollard Group Boston, Massachusetts $3.29B AUM 4.86% 1-Year Est. Return

Bodenholm Capital's BSX Position: Q3 2019 in Review

Bodenholm Capital sold out of Boston Scientific (BSX) in Q3 2019, closing a stake of 701,100 shares — an estimated $30.1M sold.

Bodenholm Capital first reported a position in BSX in Q1 2018 and held it in 2 quarters. The position peaked at $33M in Q1 2018. 771 funds tracked by Wall St. Rank hold BSX as of Q3 2019.

  • Bodenholm Capital reported no remaining Boston Scientific position as of Q3 2019 after selling out during the quarter.
  • Bodenholm Capital sold 701,100 Boston Scientific shares in Q3 2019, an estimated $30.1M.
  • Bodenholm Capital first reported a position in Boston Scientific in Q1 2018 and held it in 2 quarters.
  • Bodenholm Capital's Boston Scientific position peaked at $33M in Q1 2018.
  • 771 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2019.

Based on Bodenholm Capital's 13F filing for Q3 2019, filed 8 Nov 2019.